Webcast on Demand
On demand webcast: View the webcast from the Boehringer Ingelheim press conference at the ESC 2009 in Barcelona on 30 August.
Value through Innovation17 January 2013
Stroke Prevention in Atrial Fibrillation (SPAF) News and Information
This section includes information and resources about Stroke Prevention in Atrial Fibrillation (SPAF) for journalists: Boehringer Ingelheim press releases, background information, related press kits and a collection of images and videos.
Stroke Prevention in Atrial Fibrillation (SPAF) Press Releases
| 05.11.2012 |
FDA and EMA reaffirm important health benefits and safety of Pradaxa® (dabigatran etexilate) for patients with atrial fibrillation - For Non-US, Non-UK & Non-Canadian Media Only |
|---|---|
| 31.10.2012 |
Wealth of worldwide evidence on Pradaxa® including first clinical data on long-term efficacy and safety of a novel oral anticoagulant to be presented at AHA Scientific Sessions |
| 28.09.2012 |
Join the mission on World Heart Day 2012: call for signatures |
| 12.09.2012 |
Asian populations with atrial fibrillation (AF) benefit from better stroke prevention with Pradaxa® (dabigatran etexilate) compared to warfarin - For Non-US, Non-UK & Non-Canadian Media Only |
| 29.08.2012 |
Large scale registry shows atrial fibrillation management is suboptimal and unequal around the world - For Non-US, Non-UK & Non-Canadian Media Only |
SPAF Related News Room
SPAF Related Documents
Videos
-
-
Prof. Gregory Lip
- Watch the video(QT)
-
-
-
-
-
-
-
-
-
-
-
